Literature DB >> 12846521

An overview of shock wave therapy in musculoskeletal disorders.

Ching-Jen Wang1.   

Abstract

Shock waves are high-energy acoustic waves generated under water with high voltage explosion and vaporization. Shock wave in urology (lithotripsy) is primarily used to disintegrate urolithiasis, whereas shock wave in orthopedics (orthotripsy) is not used to disintegrate tissues, rather to induce neovascularization, improve blood supply and tissue regeneration. The application of shock wave therapy in certain musculoskeletal disorders has been around for approximately 15 years, and the success rate in non-union of long bone fracture, calcifying tendonitis of the shoulder, lateral epicondylitis of the elbow and proximal plantar fasciitis ranged from 65% to 91%. The complications are low and negligible. Recently, shock wave therapy was extended to treat other conditions including avascular necrosis of femoral head, patellar tendonitis (jumper's knee), osteochondritis dessicans and non-calcifying tendonitis of the shoulder. Shock wave therapy is a novel therapeutic modality without the need of surgery and surgical risks as well as surgical pain. It is convenient and cost-effective. The exact mechanism of shock wave therapy remains unknown. Based on the results of animal studies in our laboratory, it appears that the mechanism of shock waves first stimulates the early expression of angiogenesis-related growth factors including eNOS (endothelial nitric oxide synthase), VEGF (vessel endothelial growth factor) and PCNA (proliferating cell nuclear antigen), then induces the ingrowth of neovascularization that improves blood supply and increases cell proliferation and eventual tissue regeneration to repair tendon or bone tissues. The rise of angiogenic markers occurred in as early as one week and only lasted for approximately 8 weeks, whereas the neovascularization was first noted in 4 weeks and persisted for 12 weeks or longer along with cell proliferation. These findings support the clinical observation that the effect of shock wave therapy appears to be dose-dependent and symptom improvement with time. Additional information including the cellular and molecular changes after shock wave therapy are needed for further clarification on the mechanism of shock wave therapy in musculoskeletal system.

Entities:  

Mesh:

Year:  2003        PMID: 12846521

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  65 in total

1.  Shock wave therapy for systemic sclerosis.

Authors:  L Belloli; M Cugno; M C D'Agostino; N Ughi; A Tedeschi; S Respizzi; B Marasini
Journal:  Rheumatol Int       Date:  2011-12-25       Impact factor: 2.631

2.  [Trigger points - Diagnosis and treatment concepts with special reference to extracorporeal shockwaves].

Authors:  M Gleitz; K Hornig
Journal:  Orthopade       Date:  2012-02       Impact factor: 1.087

3.  Extracorporeal shock wave effectively attenuates brain infarct volume and improves neurological function in rat after acute ischemic stroke.

Authors:  Chun-Man Yuen; Sheng-Ying Chung; Tzu-Hsien Tsai; Pei-Hsun Sung; Tien-Hung Huang; Yi-Ling Chen; Yung-Lung Chen; Han-Tan Chai; Yen-Yi Zhen; Meng-Wei Chang; Ching-Jen Wang; Hsueh-Wen Chang; Cheuk-Kwan Sun; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

4.  Effect of low-energy shockwave therapy on angiogenic factors in the penile tissue of diabetic rats.

Authors:  Mazhar Ortaç; Canan Küçükergin; Emre Salabaş; Şule Seçkin; Ateş Kadıoğlu
Journal:  Turk J Urol       Date:  2017-05-03

5.  Acoustic field characterization of the Duolith: measurements and modeling of a clinical shock wave therapy device.

Authors:  Camilo Perez; Hong Chen; Thomas J Matula; Maria Karzova; Vera A Khokhlova
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

Review 6.  Extracorporeal shockwave therapy for the treatment of chronic wound of lower extremity: current perspective and systematic review.

Authors:  Mohammed Ta Omar; Rehab Fm Gwada; Afaf Am Shaheen; Raoul Saggini
Journal:  Int Wound J       Date:  2017-02-15       Impact factor: 3.315

Review 7.  Cellular signaling pathways modulated by low-intensity extracorporeal shock wave therapy.

Authors:  Tianshu Liu; Alan W Shindel; Guiting Lin; Tom F Lue
Journal:  Int J Impot Res       Date:  2019-01-22       Impact factor: 2.896

Review 8.  Does physical therapy and rehabilitation improve outcomes for diabetic foot ulcers?

Authors:  Yasemin Turan; Bulent M Ertugrul; Benjamin A Lipsky; Kevser Bayraktar
Journal:  World J Exp Med       Date:  2015-05-20

9.  Combination therapy with extracorporeal shock wave and melatonin markedly attenuated neuropathic pain in rat.

Authors:  Kuan-Hung Chen; Chien-Hui Yang; Christopher Glenn Wallace; Chung-Ren Lin; Chia-Kai Liu; Tsung-Cheng Yin; Tien-Hung Huang; Yi-Ling Chen; Cheuk-Kwan Sun; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

10.  The management of neuropathic ulcers of the foot in diabetes by shock wave therapy.

Authors:  Biagio Moretti; Angela Notarnicola; Giulio Maggio; Lorenzo Moretti; Michele Pascone; Silvio Tafuri; Vittorio Patella
Journal:  BMC Musculoskelet Disord       Date:  2009-05-27       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.